Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Dermatitis ; 33(1): 62-69, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35029350

RESUMEN

BACKGROUND: Shoe contact allergy can be difficult to diagnose and manage. OBJECTIVE: The aim of the study was to characterize demographics, clinical characteristics, patch test results, and occupational data for the North American Contact Dermatitis Group patients with shoe contact allergy. METHODS: This is a retrospective study of 33,661 patients, patch tested from 2005 to 2018, with a shoe source, foot as 1 of 3 sites of dermatitis, and final primary diagnosis of allergic contact dermatitis. RESULTS: Three hundred fifty-two patients met the inclusion criteria. They were more likely to be male (odds ratio = 3.36, confidence interval = 2.71-4.17) and less likely to be older than 40 years (odds ratio = 0.49, confidence interval = 0.40-0.61) compared with others with positive patch test reactions. The most common relevant North American Contact Dermatitis Group screening allergens were potassium dichromate (29.8%), p-tert-butylphenol formaldehyde resin (20.1%), thiuram mix (13.3%), mixed dialkyl thioureas (12.6%), and carba mix (12%). A total of 29.8% (105/352) had positive patch test reactions to supplemental allergens, and 12.2% (43/352) only had reactions to supplemental allergens. CONCLUSIONS: Shoe contact allergy was more common in younger and male patients. Potassium dichromate and p-tert-butylphenol formaldehyde resin were the top shoe allergens. Testing supplemental allergens, personal care products, and shoe components should be part of a comprehensive evaluation of suspected shoe contact allergy.


Asunto(s)
Alérgenos/efectos adversos , Dermatitis Alérgica por Contacto/diagnóstico , Dermatosis del Pie/diagnóstico , Zapatos/efectos adversos , Adulto , Colorantes/efectos adversos , Estudios Transversales , Dermatitis Alérgica por Contacto/etiología , Femenino , Dermatosis del Pie/etiología , Humanos , Masculino , Persona de Mediana Edad , América del Norte , Pruebas del Parche/métodos , Resinas Sintéticas/efectos adversos , Estudios Retrospectivos , Goma/efectos adversos , Adulto Joven
2.
Dermatitis ; 24(4): 176-82, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23857015

RESUMEN

BACKGROUND: Both active and inactive ingredients in sunscreen may cause contact dermatitis. OBJECTIVES: This study aimed to describe allergens associated with a sunscreen source. METHODS: A cross-sectional analysis of patients patch tested by the North American Contact Dermatitis Group between 2001 and 2010 was performed. RESULTS: Of 23,908 patients patch tested, 219 (0.9%) had sunscreen coded as an allergen source. Patients who were male, with occupational dermatitis, or older (older than 40 years) had significantly lower rates of allergic reactions to sunscreens; the most commonly affected areas were the face and exposed sites (P < 0.0001). The top 3 most frequent allergens in sunscreens were benzophenone-3 (70.2% for 10% concentration, 64.4% for 3% concentration), DL-alpha-tocopherol (4.8%), and fragrance mix I (4.0%). Less than 40% of positive patch test reactions were detected by the North American Contact Dermatitis Group screening series of 65 to 70 allergens. CONCLUSIONS: A supplemental antigen series is important in detecting allergy to sunscreens.


Asunto(s)
Alérgenos/efectos adversos , Dermatitis por Contacto/diagnóstico , Dermatitis por Contacto/epidemiología , Protectores Solares/efectos adversos , Anciano , Alérgenos/análisis , Benzofenonas/efectos adversos , Benzofenonas/análisis , Estudios Transversales , Dermatitis por Contacto/etiología , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , América del Norte/epidemiología , Pruebas del Parche , Estudios Retrospectivos , Factores de Riesgo , Protectores Solares/análisis
3.
Dermatitis ; 24(1): 10-21, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23340394

RESUMEN

BACKGROUND: The North American Contact Dermatitis Group (NACDG) tests patients with suspected allergic contact dermatitis to a broad series of screening allergens and publishes periodic reports. OBJECTIVE: The aims of this study were to report the NACDG patch-testing results from January 1, 2007, to December 31, 2008, and to compare results to pooled test data from the previous 2 and 10 years to analyze trends in allergen sensitivity. METHODS AND MATERIALS: Standardized patch testing with 65 allergens was used at 13 centers in North America. χ analysis was used for comparisons. RESULTS: A total of 5085 patients were tested; 11.8% (598) had an occupationally related skin condition, and 65.3% (3319) had at least 1 allergic patch test reaction, which is identical to the NACDG data from 2005 to 2006. The top 15 most frequently positive allergens were nickel sulfate (19.5%), Myroxylon pereirae (11.0%), neomycin (10.1%), fragrance mix I (9.4%), quaternium-15 (8.6%), cobalt chloride (8.4%), bacitracin (7.9%), formaldehyde (7.7%), methyldibromoglutaronitrile/phenoxyethanol (5.5%), p-phenylenediamine (5.3%), propolis (4.9%), carba mix (4.5%), potassium dichromate (4.1%), fragrance mix II (3.6%), and methylchloroisothiazolinone/methylisothiazolinone (3.6%). There were significant increases in positivity rates to nickel, methylchloroisothiazolinone/methylisothiazolinone, and benzophenone-3. During the same period of study, there were significant decreases in positivity rates to neomycin, fragrance mix I, formaldehyde, thiuram mix, cinnamic aldehyde, propylene glycol, epoxy resin, diazolidinyl urea, amidoamine, ethylenediamine, benzocaine, p-tert-butylphenol formaldehyde resin, dimethylol dimethyl hydantoin, cocamidopropyl betaine, glutaraldehyde, mercaptobenzothiazole, tosylamide formaldehyde resin, budesonide, disperse blue 106, mercapto mix, and chloroxylenol. Twenty-four percent (1221) had a relevant positive reaction to a non-NACDG supplementary allergen; and 180 of these reactions were occupationally relevant. CONCLUSIONS: Periodic analysis, surveillance, and publication of multicenter study data sets document trends in allergen reactivity incidence assessed in the patch test clinic setting and provide information on new allergens of relevance.


Asunto(s)
Alérgenos , Dermatitis Alérgica por Contacto/diagnóstico , Dermatitis Profesional/diagnóstico , Pruebas del Parche/métodos , Adulto , Anciano , Anciano de 80 o más Años , Alérgenos/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Dermatitis Profesional/etiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , América del Norte , Estudios Retrospectivos
4.
Dermatitis ; 21(2): 111-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20233551

RESUMEN

The etiology of cheilitis is often not readily apparent. We present a case series of four patients with allergic contact cheilitis (ACC) secondary to exposure to peppermint oil contained in a lip balm product. These patients developed eczematous dermatitis involving their lips and perioral skin. They were tested with the North American Contact Dermatitis Group standard series as well as with an expanded series of flavoring agents, sunscreens, plant and fragrance components, and their own products. The lip balm contained potential sensitizers such as propolis, lanolin, coconut oil, almond oil, peppermint oil, and vitamin E. Our patch-test results showed that peppermint oil was the most likely culprit in these patients' ACC. Peppermint oil is less commonly reported as causing ACC than are more common contactants such as balsam of Peru or nickel sulfate. However, with the widespread use of lip balms containing peppermint oil, more cases of peppermint oil-induced ACC may be expected.


Asunto(s)
Queilitis/etiología , Dermatitis Alérgica por Contacto/etiología , Emolientes/efectos adversos , Aceites de Plantas/efectos adversos , Adolescente , Adulto , Bálsamos/administración & dosificación , Bálsamos/efectos adversos , Queilitis/diagnóstico , Aceite de Coco , Dermatitis Alérgica por Contacto/diagnóstico , Eccema/etiología , Femenino , Humanos , Lanolina/efectos adversos , Lanolina/análisis , Masculino , Mentha piperita , Persona de Mediana Edad , Pruebas del Parche , Aceites de Plantas/administración & dosificación , Aceites de Plantas/análisis , Própolis/efectos adversos , Própolis/análisis , Vitamina E/efectos adversos , Vitamina E/análisis
5.
J Cutan Med Surg ; 10(4): 166-9, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17234114

RESUMEN

BACKGROUND: Cutaneous atypical mycobacterial infections have been increasingly described in association with cosmetic and alternative procedures. OBJECTIVE: We report an outbreak of acupuncture-associated mycobacteriosis. Between April and December 2002, 32 patients developed cutaneous mycobacteriosis after visiting an acupuncture practice in Toronto, Canada. RESULTS: Of 23 patients whose lesions were biopsied, 6 (26.1%) had culture-confirmed infection with Mycobacterium abscessus. These isolates were genetically indistinguishable by amplified fragment length polymorphism. The median incubation period was 1 month. Of 24 patients for whom clinical information was available, 23 (95.8%) had resolution of their infection. All patients developed residual scarring or hyperpigmentation. CONCLUSION: Nontuberculous mycobacteria should be recognized as an emerging, but preventable, cause of acupuncture-associated infections.


Asunto(s)
Terapia por Acupuntura/efectos adversos , Brotes de Enfermedades , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Infecciones por Mycobacterium no Tuberculosas/etiología , Enfermedades Cutáneas Bacterianas/epidemiología , Enfermedades Cutáneas Bacterianas/etiología , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Control de Infecciones/normas , Masculino , Persona de Mediana Edad , Agujas , Ontario/epidemiología , Estudios Retrospectivos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA